Silco Pharmaceuticals Limited announcements
108 Dhaka Stock Exchange announcements for Silco Pharmaceuticals Limited (SILCOPHL) since 2020: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2025 (16).
- Emphasis of Matters
The auditor of the company has given the Emphasis of Matters paragraph in the audited financial statements of the company for the year ended June 30, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/Silco%20Pharmaceuticals%20Limited_2025.pdf
- Resumption after Record Date
Trading of the shares of the company will resume on 17.12.2025.
- Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 15.12.2025.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 11.12.2025 to 14.12.2025 and trading of the shares will remain suspended on record date i.e., 15.12.2025.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.16 for July-September 2025 as against Tk. 0.17 for July-September 2024. NOCFPS was Tk. 0.27 for July-September 2025 as against Tk. 0.24 for July-September 2024. NAV per share was Tk. 23.18 as on September 30, 2025 and Tk. 23.02 as on June 30, 2025.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 30, 2025 at 3:30 PM to consider, among others, Un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2025.
- Dividend Declaration
The Board of Directors has recommended 1.10% Cash Dividend for all shareholders excluding Directors for the year ended June 30, 2025. The Directors hold 36,615,370 shares out of the total 103,807,000 shares of the company and Cash Dividend payable to the General Shareholders, Independent Directors and Sponsors only is Tk. 7,391,079.00 for 67,191,630 shares. (cont.) (Cont. News of SILCOPHL): Date of AGM: 19.01.2026, Time: 11:30 AM, Venue: Hybrid System: Online and Physical Platform at registered office premises. Record Date: 15.12.2025. The Company has also reported EPS of Tk. 0.41, NAV per share of Tk. 23.02, and NOCFPS of Tk. 0.74 for the year ended June 30, 2025, as against EPS of Tk. 0.44, NAV per share of Tk. 22.66, and NOCFPS of Tk. 0.81 for the year ended June 30, 2024. (end)
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (18.11.2025) following its corporate declaration.
- Update of Information
The company has requested the shareholders to check and update their respective BO ID's, Bank A/c details along with routing number to get dividend online through BEFTN system. The company has also requested to provide 12 digits e-TIN to BO A/c and get Tax deduction @ 10% instead of 15%.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 17, 2025 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2025.
- Transmission of Deceased Sponsor Director's shares to his nominee
Prof. Dr. Azizur Rahman, one of the Sponsor Directors of the company, passed away on 12.05.2025. The company has informed that his holding of 3,317,457 shares will be transmitted to the account of his nominee Ms. Rowshan Ara Chowdhury, who is wife of Prof. Dr. Azizur Rahman.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.13 for January-March 2025 as against Tk. 0.16 for January-March 2024; EPS was Tk. 0.40 for July 2024-March 2025 as against Tk. 0.39 for July 2023-March 2024. NOCFPS was Tk. 0.71 for July 2024-March 2025 as against Tk. 0.68 for July 2023-March 2024. NAV per share was Tk. 23.01 as on March 31, 2025 and Tk. 22.66 as on June 30, 2024.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2025 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2025.
- Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2024 to the respective shareholders.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.10 for October-December 2024 as against Tk. 0.12 for October-December 2023; EPS was Tk. 0.27 for July-December 2024 as against Tk. 0.23 for July-December 2023. NOCFPS was Tk. 0.62 for July-December 2024 as against Tk. 0.37 for July-December 2023. NAV per share was Tk. 22.94 as on December 31, 2024 and Tk. 22.66 as on June 30, 2024.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2025 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2024.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.